BOSTON–(BUSINESS WIRE)–Ukko, Inc., a biotechnology company re-inventing immunotherapy for allergic diseases, today announced a summary of 2025 operational achievements and provided a strategic outlook for 2026. Read more...
Read MoreTEL AVIV, Israel, Jan. 8, 2026 /PRNewswire/ — SeeTrue AI, a global leader in AI-powered security screening, is proud to announce that its SeeTrue Automated Prohibited Items Detection Software (APIDS) has become the first and only solution to receive European Civil Aviation Conference (ECAC) certification for use with the Analogic ConneCT and Rapiscan 920CT EDSCB machines. Read...
Read MoreLAS VEGAS—Intuition Robotics has announced ElliQ’s new health agent capabilities, an expansion of the ElliQ robot that turns the artificial intelligence (AI) companion into a proactive health agent, increasing insights on health and functional status as well as adherence on medications, screenings, wellness activities, lifestyle recommendations and clinical action plans. Read more...
Read MoreSAN JOSE, Calif., Jan. 07, 2026 (GLOBE NEWSWIRE) — BrightInsight, Inc. (“BrightInsight”), a leader in digital health solutions, today shared new data from its collaboration with Sanofi and its partner, Regeneron, highlighting the positive impact of the Patient App on adherence and persistence for one of Sanofi and Regeneron’s key biologic therapies. Read...
Read MoreAnthropic, the developer of the chatbot Claude, plans to raise $10 billion at a valuation of $350 billion before the new investment, according to people familiar with the matter, nearly doubling its valuation from four months ago. Read...
Read More
